TY - JOUR
TI - Mobile Technology in Allergic Rhinitis: Evolution in Management or Revolution in Health and Care?
AU - Bousquet, J.
AU - Ansotegui, I.J.
AU - Anto, J.M.
AU - Arnavielhe, S.
AU - Bachert, C.
AU - Basagaña, X.
AU - Bédard, A.
AU - Bedbrook, A.
AU - Bonini, M.
AU - Bosnic-Anticevich, S.
AU - Braido, F.
AU - Cardona, V.
AU - Czarlewski, W.
AU - Cruz, A.A.
AU - Demoly, P.
AU - De Vries, G.
AU - Dramburg, S.
AU - Mathieu-Dupas, E.
AU - Erhola, M.
AU - Fokkens, W.J.
AU - Fonseca, J.A.
AU - Haahtela, T.
AU - Hellings, P.W.
AU - Illario, M.
AU - Ivancevich, J.C.
AU - Jormanainen, V.
AU - Klimek, L.
AU - Kuna, P.
AU - Kvedariene, V.
AU - Laune, D.
AU - Larenas-Linnemann, D.
AU - Lourenço, O.
AU - Onorato, G.L.
AU - Matricardi, P.M.
AU - Melén, E.
AU - Mullol, J.
AU - Papadopoulos, N.G.
AU - Pfaar, O.
AU - Pham-Thi, N.
AU - Sheikh, A.
AU - Tan, R.
AU - To, T.
AU - Tomazic, P.V.
AU - Toppila-Salmi, S.
AU - Tripodi, S.
AU - Wallace, D.
AU - Valiulis, A.
AU - van Eerd, M.
AU - Ventura, M.T.
AU - Yorgancioglu, A.
AU - Zuberbier, T.
JO - The Journal of Allergy and Clinical Immunology: In Practice
PY - 2019
VL - 7
TODO - 8
SP - 2511-2523
PB - American Academy of Allergy, Asthma and Immunology
SN - 2213-2198
TODO - 10.1016/j.jaip.2019.07.044
TODO - allergen;  antiallergic agent;  pollen antigen, allergic rhinitis;  Article;  clinical decision support system;  conceptual framework;  cost effectiveness analysis;  desensitization;  disease exacerbation;  empowerment;  European Union;  evolution;  government regulation;  health care delivery;  health promotion;  human;  Internet;  medical information;  medical information system;  medical technology;  mobile application;  patient assessment;  patient attitude;  patient care;  patient compliance;  phenotype;  practice guideline;  public health service;  risk factor;  allergic rhinitis;  clinical trial;  Europe;  multicenter study;  smartphone;  telemedicine, Delivery of Health Care;  Europe;  Humans;  Mobile Applications;  Phenotype;  Rhinitis, Allergic;  Risk Factors;  Smartphone;  Telemedicine
TODO - Smart devices and Internet-based applications (apps) are largely used in allergic rhinitis and may help to address some unmet needs. However, these new tools need to first of all be tested for privacy rules, acceptability, usability, and cost-effectiveness. Second, they should be evaluated in the frame of the digital transformation of health, their impact on health care delivery, and health outcomes. This review (1) summarizes some existing mobile health apps for allergic rhinitis and reviews those in which testing has been published, (2) discusses apps that include risk factors of allergic rhinitis, (3) examines the impact of mobile health apps in phenotype discovery, (4) provides real-world evidence for care pathways, and finally (5) discusses mobile health tools enabling the digital transformation of health and care, empowering citizens, and building a healthier society. © 2019 American Academy of Allergy, Asthma & Immunology
ER -